M. S. Hosseini-Zare et al. / Tetrahedron Letters 53 (2012) 3448–3451
3451
9. Katritzky, A. R.; He, H.-Y.; Verma, A. K. Tetrahedron: Asymmetry 2002, 13, 933–938.
10. Sulkowski, T. S. U.S. Patent 3,994,920, 1976; Chem. Abstr. 1977, 86, 106681p.
11. Metlesics, W.; Anton, T.; Sternbach, L. H. J. Org. Chem. 1967, 32, 2185–2187.
12. Gomes, P.; Araujo, M. J.; Rodrigues, M.; Vale, N.; Azevedo, Z.; Iley, J.; Chambel,
P.; Morais, J.; Moreira, R. Tetrahedron 2004, 60, 5551–5562.
13. Tahghighi, A.; Marznaki, F. R.; Kobarfard, F.; Dastmalchi, S.; Mojarrad, J. S.;
Razmi, S.; Ardestani, S. K.; Emami, S.; Shafiee, A.; Foroumadi, A. Eur. J. Med.
Chem. 2011, 46, 2602–2608.
14. Fallah-Tafti, A.; Foroumadi, A.; Tiwari, R.; Shirazi, A. N.; Hangauer, D. G.; Bu, Y.;
Akbarzadeh, T.; Parang, K.; Shafiee, A. Eur. J. Med. Chem. 2011, 46, 4853–4858.
15. Foroumadi, A.; Emami, S.; Mansouri, S.; Javidnia, A.; Saeid-Adeli, N.; Shirazi, F.
H.; Shafiee, A. Eur. J. Med. Chem. 2007, 42, 985–992.
conditions. The procedure is very simple and affords the deriva-
tives in good yields in the absence of a catalyst.
Acknowledgements
This research was supported by grants from the research coun-
cil of Tehran University of Medical Sciences and the Iran National
Science Foundation (INSF).
16. Khalaj, A.; Nakhjiri, M.; Negahbani, A. S.; Samadizadeh, M.; Firoozpour, L.;
Rajabalian, S.; Samadi, N.; Faramarzi, M. A.; Adipour, N.; Shafiee, A.; Foroumadi,
A. Eur. J. Med. Chem. 2011, 46, 65–70.
Supplementary data
17. Wolkenberg, S. E.; Wisnoski, D. D.; Leister, W. H.; Wang, Y.; Zhao, Z.; Lindsley,
C. W. Org. Lett. 2004, 6, 1453–1456.
18. Usyatinsky, A. Y.; Khmelnitsky, Y. L. Tetrahedron Lett. 2000, 41, 5031–5034.
19. Khosropour, A. R. Ultrason. Sonochem. 2008, 15, 659–664.
20. Shelke, K. F.; Sapkal, S. B.; Sonar, S. S.; Madje, B. R.; Shingate, B. B.; Shingare, M.
S. Bull. Korean Chem. Soc. 2009, 30, 1057–1060.
Supplementary data associated with this article can be found, in
088. These data include MOL files and InChiKeys of the most
important compounds described in this article.
21. (a)Weiss, M. J. Am. Chem. Soc. 1952, 74, 200–202; (b)Davidson, D. J. Am. Chem. Soc.
1936, 58, 1821–1822; (c) Davidson, D.; Epstein, E. J. Org. Chem. 1936, 1, 305–314.
22. General procedure for the preparation of compounds 4: A mixture of 1,2-
diketone 1 (1 mmol), 2-formylbenzoic acid 2 (1 mmol), NH4OAc (3) (excess),
and AcOH (5 mL) was heated at reflux for 5 h. Upon completion of the reaction,
the mixture was cooled to room temperature and poured into cold H2O to
precipitate the crude product. Recrystallization from petroleum ether–EtOAc
gave the pure product 4. Compound 4a: Yield 85%, colorless crystals, mp 293–
References and notes
1. Lombardino, J. G.; Wiseman, E. H. J. Med. Chem. 1974, 17, 1182–1188.
2. Zhang, C.; Sarshar, S.; Moran, E. J.; Krane, S.; Rodarte, J. C.; Benbatoul, K. D.;
Dixon, R.; Mjalli, A. M. M. Bioorg. Med. Chem. Lett. 2000, 10, 2603–2605.
3. Poorrajab, F.; Ardestani, S. K.; Emami, S.; Behrouzi-Fardmoghaddam, M.;
Shafiee, A.; Foroumadi, A. Eur. J. Med. Chem. 2009, 44, 1758–1762.
4. Barta, T. E.; Stealey, M. A.; Collins, P. W.; Weier, R. M. Bioorg. Med. Chem. Lett.
1998, 8, 3443–3448.
5. Plummer, C. W.; Finke, P. E.; Mills, S. G.; Wang, J.; Tong, X.; Doss, G. A.; Fong, T.
M.; Lao, J. Z.; Schaeffer, M.-T.; Chen, J.; Shen, C.-P.; Stribling, D. S.; Shearman, L.
P.; Strack, A. M.; Van der Ploeg, L. H. T. Bioorg. Med. Chem. Lett. 2005, 15, 1441–
1446.
6. Jamalian, A.; Shafiee, A.; Hemmateenejad, B.; Khoshneviszadeh, M.; Miri, R.;
Madadkar-Sobhani, A.; Bathaie, S. Z.; Moosavi-Movahedi, A. A. J. Iran. Chem. Soc.
2011, 8, 1098–1112.
7. Geigy, J. R. Neth. Appl. 6,613,264, 1967; Chem. Abstr. 1967, 67, 82204q.
8. (a) Graf, W. Swiss 481,123, 1969; Chem. Abstr. 1970, 72, 100709t; (b) Graf, W.
Swiss 481,124, 1969; Chem. Abstr. 1970, 72, 100710m.
294 °C; IR (KBr): 3058, 2933, 1595 cmÀ1 1H NMR (DMSO-d6, 500 MHz):
;
dH = 7.30–7.33 (m, 2H), 7.37–7.40 (m, 4H), 7.50–7.53 (m, 5H), 7.62–7.65 (m,
1H), 7.83–7.85 (dd, J = 1.05, 1.1 Hz, 1H), 7.89–7.91 (d, J = 7.0 Hz, 1H); 13C NMR
(DMSO-d6, 125 MHz): dC = 169.1, 144.9, 132.7, 132.5, 132.0, 130.7, 130.1, 129.0,
128.8, 128.5, 127.6, 127.3; MS m/z (%) = 322 (M+, 23), 296 (82), 190 (30), 165
(100); Anal. Calcd for C22H14N2O: C, 81.97; H, 4.38; N, 8.69. Found: C, 82.10; H,
4.44; N, 8.75. Compound 4b: Yield 90%, colorless crystals, mp 180–181 °C; IR
(KBr): 3058, 2939, 1643 cmÀ1 1H NMR (DMSO-d6, 500 MHz): dH = 3.73 (s, 3H),
;
3.83 (s, 3H), 6.95–6.97 (d, J = 8.6 Hz, 1H), 7.23–7.47 (m, 10H), 7.71–7.73 (d,
J = 8.5 Hz, 1H); 13C NMR (DMSO-d6, 125 MHz): dC = 171.5, 152.6, 146.3, 144.1,
137.2, 133.5, 128.6, 127.1, 126.9, 123.4, 118.4, 110.4, 60.5, 55.6; MS m/z
(%) = 382 (M+, 90), 342 (100), 299 (20), 165 (30); Anal. Calcd for C24H18N2O3: C,
75.38; H, 4.74; N, 7.33. Found: C, 75.45; H, 4.60; N, 7.25.